Welcome Message

Join us for the 14^th European Endocrinology and Diabetes Congress, taking place in the beautiful city of Paris, France on November 27-28, 2024. "Endocrinology and Diabetes” this congress will explore a diverse range of topics, providing attendees with the opportunity to gain comprehensive insights into both Endocrinology and Diabetes. Connect with esteemed speakers from around the globe, share experiences, and keep abreast of the latest developments in the field. We warmly welcome all participants interested in contributing their research and data to this collaborative platform. Endocrinology 2024 aims to bring together top experts worldwide to delve into cutting-edge research within the Endocrinology and Diabetes field and offers a unique platform for global collaboration in business.

About Conference

Join us at the "14^th European Endocrinology and Diabetes Congress" on November 27-28, 2024, in the beautiful city of Paris, France. Our theme, "Mastering the Duo: Endocrinology and Diabetes," promises a comprehensive exploration of these vital medical fields. This congress offers a diverse range of topics, providing attendees with the opportunity to delve into all aspects of Endocrinology and Diabetes. Engage with globally recognized speakers, exchange experiences, and stay abreast of the latest advancements in the field. We wholeheartedly welcome all participants interested in contributing their valuable research and data to our collaborative platform. Endocrinology 2024 unites leading experts from around the world to explore cutting-edge research, providing a unique platform for collaboration with global business delegates and researchers. Join us for invaluable insights into the causes and management of these critical health issues. 

Session And Tracks

Sessions

Track 1: Overview of Diabetes

Providing a comprehensive understanding of diabetes mellitus, covering its epidemiology, etiology, pathophysiology, and diagnostic criteria to lay the foundation for subsequent discussions on management and complications. Keynote speakers, including leading endocrinologists and researchers, will discuss advances in glucose monitoring, insulin therapy, and emerging technologies in diabetes care.

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Diabetes Mellitus

Track 2: Diabetic Complications

Exploring the multifaceted complications arising from diabetes, including microvascular (retinopathy, nephropathy) and macrovascular (cardiovascular disease, neuropathy) complications, alongside strategies for prevention, early detection, and optimal management. The session will also highlight the importance of integrated care approaches, patient education, and lifestyle modifications in reducing the risk and severity of diabetic complications.

• Foot Complications
• Gastroparesis
• Hypoglycaemia

Track 3: Obesity-Related Diabetes

Investigating the intricate relationship between obesity and diabetes, focusing on the mechanisms linking adiposity, insulin resistance, and metabolic dysfunction, and exploring tailored approaches to managing diabetes in the context of obesity. Experts will also discuss strategies for effective lifestyle interventions, patient education, and long-term management to prevent and treat obesity-related diabetes.

• Beta Cell Dysfunction
• Inflammation
• Dyslipidaemia
• Central Obesity

Track 4: Insulin Therapy

Delving into the principles, modalities, and advancements in insulin replacement therapy for diabetes management, encompassing insulin types, administration techniques, dose titration, and strategies to optimize glycemic control while minimizing hypoglycemia and other adverse effects. Practical strategies for patient education, adherence, and optimizing glycemic control will be highlighted.

Track 5: Pediatric Endocrinology

Addressing the unique aspects of diagnosing, treating, and managing endocrine disorders in podiatric populations, encompassing growth disorders, puberty-related issues, congenital adrenal hyperplasia, diabetes, and other hormone-related conditions. Leading podiatric endocrinologists will present the latest research, clinical guidelines, and innovative treatment approaches tailored to the paediatric population.

• Growth Disorders
• Diabetes in Children
• Genetic Syndromes

Track 6: Neuroendocrinology

Exploring the intricate interplay between the endocrine system and the central nervous system, elucidating neuroendocrine pathways, and their roles in regulating homeostasis, stress responses, mood, behavior, and reproductive function. Participants will gain insights into the regulatory mechanisms governing hormone secretion and the impact of the central nervous system on endocrine function.

• Neuroendocrine Disorders
• Stress Response
• Neurotransmitters
• Hypothalamus-Pituitary Axis
• Hormonal Regulation

Track 7: Endocrine Glands

Delving into the latest advancements in basic and translational research focused on elucidating the physiology, pathophysiology, and therapeutic targets of endocrine glands, spanning from molecular mechanisms to clinical applications. Participants will learn about the major endocrine glands, including the thyroid, adrenal, pituitary, and pancreas, and their hormone secretions.

• Types of Glands
• Molecular Biology
• Signal Transduction
• Therapeutics

Track 8: Reproductive Endocrinology

Investigating the hormonal regulation of reproductive function, fertility, menstrual health, and sexual development, as well as the diagnosis and treatment of disorders affecting the reproductive system in both men and women. This session is crucial for healthcare professionals and researchers seeking to enhance their knowledge and improve patient outcomes in reproductive health and endocrinology.

• Menstrual Disorders
• Polycystic Ovary Syndrome
• Infertility
• Hormone Replacement Therapy
• Reproductive Endocrine Disorders
• Assisted Reproductive Technologies

Track 9: Thyroid Imbalance Insights

Providing insights into the spectrum of thyroid disorders, including hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer, exploring diagnostic modalities, treatment options, and considerations for personalized management. The session will also address the challenges of managing thyroid imbalances in special populations, including pregnant women and the elderly.

• Autoimmune Thyroid Disorders
• Treatment Options
• Thyroid Function Tests

Track 10: Endocrine Disorders

Surveying the landscape of various endocrine disorders, beyond diabetes and thyroid conditions, including adrenal, pituitary, gonadal, and parathyroid disorders, highlighting their clinical presentations, diagnostic approaches, and management strategies. This session is crucial for healthcare professionals dedicated to advancing their understanding and treatment of endocrine diseases.

• Pancreatic Disorders
• Genetic Endocrine Disorders
• Diabetes Mellitus

Track 11: Metabolic Syndrome

Investigating the constellation of metabolic abnormalities underlying metabolic syndrome, including central obesity, dyslipidaemia, hypertension, and insulin resistance, and discussing the implications for cardiovascular risk assessment and targeted interventions. The session will cover evidence-based interventions such as lifestyle modifications, pharmacotherapy, and novel therapies aimed at managing and preventing metabolic syndrome and its associated complications.

• Abdominal Obesity
• Dyslipidemia
• High Blood Sugar

Track 12: Mental Health in Endocrine Care

Examining the bidirectional relationship between mental health disorders and endocrine conditions, addressing the impact of hormonal imbalances on mood, cognition, and behaviour, and integrating mental health considerations into comprehensive endocrine care. Participants will examine how conditions such as diabetes, thyroid disorders, and adrenal dysfunction can influence mental health outcomes such as depression, anxiety, and cognitive function.

• Psychological Impact
• Emotional Well-being
• Psychiatric Comorbidities

Track 13: Endocrine Oncology

Scrutinizing the diagnosis, staging, treatment modalities, and multidisciplinary management of endocrine-related malignancies, encompassing thyroid, adrenal, pituitary, and neuroendocrine tutors, and addressing emerging therapeutic approaches and challenges. Expert speakers will discuss the latest advancements in oncology research, including molecular diagnostics, targeted therapies, and immunotherapy approaches specific to endocrine malignancies.

• Thyroid Cancer
• Adrenal Tumours
• Pituitary Tumours
• Parathyroid Cancer
• Neuroendocrine Tumours
• Endocrine Pancreatic Tumours
• Surgical Interventions

Track 14: Endocrine Genomics Essentials

Providing foundational insights into the role of genetics and genomics in shaping endocrine function, disorders, and personalized therapeutic strategies, highlighting key genetic variants, genomic technologies, and implications for precision medicine. This session is essential for healthcare professionals seeking to enhance their understanding of genetic influences on endocrine health and disease.

• Genetic Screening
• Gene Expression Profiling
• Pharmacogenomics
• Genetic Counselling
• Polygenic Risk

Track 15: Radiological Approaches in Endocrinology

Exploring the utility, indications, and interpretations of various radiological imaging modalities in diagnosing and monitoring endocrine disorders, from ultrasound to nuclear medicine, and discussing advancements in radiological techniques and their applications. Participants will explore a variety of radiological modalities such as ultrasound, CT scan, MRI, nuclear medicine, and PET scans, emphasizing their applications in evaluating thyroid nodules, adrenal tumours, pituitary adenomas, and other endocrine conditions.

• Imaging Modalities
• Functional Imaging
• Image-Guided Interventions
• Multimodal Imaging

Track 16: Precision Medicine in Endocrine Practice

Delving into the paradigm shift toward personalized approaches to diagnosing, treating, and managing endocrine disorders, leveraging genomic, molecular, and clinical data to tailor interventions to individual patient characteristics and optimize outcomes. The session will highlight innovative strategies for risk prediction, treatment response prediction, and patient stratification, emphasizing the role of big data analytics and artificial intelligence in advancing precision medicine in endocrine practice.

Track 17: Dietary Interventions in Endocrinology

Investigating the impact of dietary factors and interventions on endocrine health, including nutritional approaches to diabetes management, weight loss, metabolic syndrome, and other hormone-related conditions, and exploring dietary guidelines and lifestyle modifications. Expert speakers will discuss the impact of macronutrients, micronutrients, and dietary patterns on hormonal regulation, insulin sensitivity, and metabolic pathways.

• Diabetes Management
• Weight Management
• Calcium and Vitamin D Supplementation
• Medical Nutrition Therapy
• Behavioral Counseling

Track 18: Remote Endocrine Care

Exploring the evolving landscape of telemedicine and remote monitoring in delivering endocrine care, encompassing virtual consultations, telehealth platforms, digital health technologies, and their implications for improving access, convenience, and patient outcomes. The session will address regulatory considerations, reimbursement policies, and ethical implications associated with remote endocrine consultations.

Track 19: Endo Case Challenges

Engaging participants in interactive case-based discussions to navigate complex clinical scenarios and diagnostic dilemmas encountered in endocrine practice, fostering critical thinking, problem-solving skills, and collaborative decision-making in real-world contexts. Healthcare providers will gain valuable practical knowledge, diagnostic strategies, and therapeutic insights to enhance their clinical practice and improve patient outcomes in challenging endocrine cases.

Why To Attend?

Attending the Endocrinology Meet 2024 conference is essential for anyone involved in the field of endocrinology. This gathering offers a unique platform to stay updated on the latest research, breakthroughs, and advancements in endocrine disorders and treatments. Through engaging presentations, interactive sessions, and networking opportunities, attendees can expand their knowledge, exchange ideas, and establish valuable connections with peers and experts.

Who can attend?

The Endocrinology Meet 2024 conference welcomes a diverse audience, including endocrinologists, researchers, clinicians, healthcare professionals, educators, students, and industry representatives. With sessions tailored to various interests and expertise levels, attendees can engage in discussions, share insights, and stay updated on the latest advancements in the field.

Target Audience

• Endocrinologists
• Diabetologists
• Diabetes educators
• Researchers in endocrinology and diabetes
• Clinical researchers
• Healthcare professionals
• Dietitian
• Neurologists
• Ophthalmologist
• Cardiologists
• Nephrologists
• Diabetes societies & associations
• Medical & Pharmaceutical companies
• Primary care physicians
• Nurse practitioners
• Pharmacists
• Students
• Industry professionals
• Policy makers

Benifits Of Participation

Participation Benefits :

• Benefit from attending keynote presentations by esteemed researchers.
• Gain access to all sessions and networking opportunities.
• Receive global recognition for your research and profile.
• Get the opportunity to publish abstracts in international journals with unique DOIs.
• Obtain discounts for publishing articles in open-access journals.
• Receive handbooks and conference kits to enhance your experience.
• Network with prominent figures from around the globe.
• Learn and expand your knowledge from top professionals in the field.
• Receive certified participation for your abstracts.
• Establish global connections for your research ideas and professional growth.

Participation categories:

• Keynote Speaker: Share your insights as a prominent figure in the field in a 45-50 minute presentation.
• Speaker (Oral Presentation): Showcase your individual research or expertise in a 25-30 minute presentation.
• Speaker (Workshop): Provide interactive learning experiences in a 45-50 minute workshop.
• Speaker (Special Session): Contribute to a special session for 45-50 minutes alongside fellow experts.
• Speaker (Symposium): Collaborate with multiple presenters in a symposium lasting more than 45 minutes.
• Delegate (Registration Only): Access all sessions and benefits upon registration.
• Poster Presenter: Showcase your research through poster presentations and enjoy delegate benefits.
• Remote Attendance: Participate via video or e-poster presentation.
• Exhibitor: Display your company products through booked booths of varying sizes.
• Media Partner, Sponsor, and Collaborator: Collaborate with the event, offering support and visibility.

Market Analysis

The Endocrinology Meet 2024 is set to showcase the latest advancements in Endocrinology and Diabetes research, including new insulin analogues, cutting-edge technologies and devices for diabetic prevention, and innovative treatments for obesity and more. This conference will not only expand your practical and theoretical knowledge but also offer a unique opportunity to connect with experts in the field. Diabetes mellitus (DM) currently affects an estimated 29.1 million individuals in the United States, ranking as the 7th leading cause of death. It has been found to increase the all-cause mortality rate 1.8 times compared to individuals without diagnosed diabetes, and poses a 1.8 times greater risk of heart attack. The financial impact is also significant, with the estimated total cost of DM in the United States in 2012 reaching $245 billion, covering medical care, disability, and premature death expenses. The significance of diabetes and its associated conditions will continue to grow as the population ages. As such, the assessment of therapies proven to reduce microvascular and macrovascular complications needs to account for newly identified comorbidities.

The market value relating to diabetic research is equally noteworthy, with projections indicating that more than 150 million individuals are expected to have diabetes by 2040. According to the International Diabetes Federation, China has surpassed all other countries in the number of diabetes cases, with estimates of over 100 million reported cases, a figure expected to rise to 151 million by 2040.

Visa Trip Advisor

Planning a trip to Paris, France? Attend our Meeting!

Issue with VISA?

To support participants in their VISA application process, we provide VISA support documents as follows:

1. Official Letter of Invitation
2. Official Letter of Abstract Acceptance
3. Receipt of Payment

Points to note:

• Visa Letter (official letter of invitation) will be issued only after successful registration and payment for the conference.
• Visa Letters can be issued only for the individual accepted to attend the conference.
• Please contact the Program Manager - Elena Hawkins, via endocrinology@europeconferences.net to arrange for a Visa Letter.

Kindly provide us with the following information for Visa Letters:

• Your name as it appears on your passport
• Passport Scan Copy (passport number and date of birth)
• Abstract Acceptance letter

Payment Methods:

1. Payment Gateway - RAZORPAY
2. Bank-to-Bank transfer

Having trouble with registration?

Please contact Program Manager – Elena Hawkins via endocrinology@europeconferences.net. The ENDOCRINOLOGY 2024 team will provide you with an INVOICE for the requested price, enabling you to make the Bank-to-Bank transfer.

Past Conference Report

Endocrinology Congress 2018

Past Reports  Gallery  

Endocrinology 2017

Past Reports  Gallery  

Diabetes and Endocrinology 2016

Past Reports  Gallery  

Endocrinology 2015

Past Reports  Gallery